Bilobil, 40 mg capsules 60 pcs

Hearing impairment, Attention and memory impairment, Visual impairment, Headache, Impaired cerebral circulation, Concussion and other craniocerebral injuries, Prevention of thrombosis, Visual impairment

– Symptomatic treatment of cognitive disorders in adults.

– As part of the complex therapy of vertigo of vestibular origin as adjunctive treatment in addition to vestibular rehabilitation.

– Symptomatic treatment of tinnitus (ringing or tinnitus).

Active ingredient

Composition

1 capsule contains:

Active ingredients:

Ginkgo biloba leaf extract (Ginkgo biloba leaf extract dry*) 40.00 mg

Auxiliary substances:

Liquid dextrose [dextrose, oligo- and polysaccharides], lactose monohydrate, corn starch, talcum, colloidal silicon dioxide, magnesium stearate

Composition of hard gelatin capsule (body and cap):

Black iron oxide dye (E172), red iron oxide dye (E172), titanium dioxide (E171), indigo carmine (E132), azorubin dye (E122), gelatin

* Ginkgo biloba leaf extract dried from Ginkgo biloba leaves (Ginkgo biloba L., family Ginkgoaceae, folium).

Ratio of amount of medicinal plant material to the amount of the initial extract: 35-67:1. The extractant is acetone/water.

How to take, the dosage

Ingestion. Capsules should be swallowed whole with small amount of water, regardless of the time of meal.

In symptomatic treatment of cognitive disorders in adults: 1-2 capsules 3 times a day. In dizziness of vestibular origin and symptomatic treatment of tinnitus: 3 capsules a day, distributed throughout the day.

The first signs of improvement usually appear after 1 month.

Course of treatment is at least 3 months (especially for elderly patients). A repeat course is possible after consulting a physician.

If the drug was missed or an insufficient amount was taken, the subsequent administration should be carried out as indicated in these instructions, without any changes.

Interaction

Bilobil® is not recommended for patients who regularly take acetylsalicylic acid, anticoagulants (direct and indirect action), as well as thiazide diuretics, tricyclic antidepressants, anticonvulsants, gentamicin.

Special Instructions

Use with caution in patients with epilepsy, arterial hypotension.

It is contraindicated in persons under 18 years of age (effectiveness and safety have not been studied).

Perform with caution in patients with epilepsy, arterial hypotension.

Do not exceed the recommended doses of Bilobil®.

If a hypersensitivity reaction develops, the use of the drug should be discontinued. Before surgery, the physician should be informed about the use of Bilobil®.

In case of frequent feelings of dizziness and tinnitus, a physician should be consulted. In case of a sudden worsening or loss of hearing, consult a physician immediately. Patients with bleeding disorder (hemorrhagic diathesis) and patients receiving anticoagulant therapy should consult a physician before starting therapy with Bilobil®.

It is not recommended to use Bilobil® together with ethanol.

Epileptic seizures may occur in patients with epilepsy when using Ginkgo biloba products.

Special information about the excipients

1 capsule of Bilobil® contains 98 mg of digestible carbohydrates (glucose, lactose, starch), which corresponds to 0.0082 bread units (BE), the maximum daily dose (6 capsules) corresponds to 0.049 BE.

Bilobil® contains the dye azorubin (E122) which may cause allergic reactions.

While taking Bilobil® > Care should be taken when performing potentially dangerous activities requiring high concentration and quick psychomotor reactions (including driving vehicles, operating moving mechanisms) and in case of adverse reactions, including dizziness, one should refrain from driving vehicles.

Synopsis

Solid gelatin capsules № 4, the body and cap are purple-brown. The contents of the capsules – powder from light brown to dark brown in color with particles of darker color. Small lumps are allowed.

.

Contraindications

Hypersensitivity to the components of the drug, decreased blood clotting, erosive gastritis in the acute stage, gastric and duodenal ulcer in the acute stage, acute disorders of cerebral circulation, acute myocardial infarction, pregnancy, breast feeding, children under 18 years old (efficacy and safety have not been studied), lactose intolerance, lactase deficiency, glucose-galactose malabsorption syndrome (composition of Bilobil® contains lactose).

Side effects

Classification of frequency of side effects according to World Health Organization (WHO) recommendations:

very frequently ≥1/10

often ≥ 1/100 to < 1/10

frequently from ≥ 1/1000 to < 1/100

often from ≥ 1/10000 to < 1/1000

very rarely from < 1/10000, including individual reports

frequency unknown cannot be estimated based on available data.

From the digestive system:

very rarely: nausea, vomiting, diarrhea.

From the nervous system:

very rarely: headache, dizziness, insomnia.

Allergic reactions:

very rarely: hyperemia, edema, skin itching.

Hemostasis system:

very rarely: decreased blood clotting. There are reports on the occurrence of bleeding during prolonged use of Ginkgo biloba products in patients who simultaneously took agents that reduce blood clotting.

Senses:

frequency unknown: hearing loss.

In case of any adverse events, the drug should be stopped and a physician should be consulted.

Overdose

There have been no reports of overdose of Bilobil® at present. In case of overdose, treatment is symptomatic.

Pregnancy use

The use of Bilobil® is contraindicated in pregnancy and during breastfeeding, due to a lack of sufficient clinical data.

Similarities